The latest news updates from the 2024 Symposium
Sacha Howell, PhD, FRCP, and Angel Guerrero-Zotano, MD, PhD, discuss their Friday morning poster presentations.
Malcolm Bevel, PhD, MSPH; Richard J. Bleicher, MD, FACS; and Marcela Mazo-Canola, MD, discuss their Friday morning poster presentations.
Findings from the HER2CLIMB-02 trial and late-breaking final overall survival results from MONARCH 3 were presented on Wednesday during the first General Session of the 2023 SABCS®.
Jack Cuzick, PhD, a pioneer in breast cancer prevention research, received the William L. McGuire Memorial Lecture Award on Wednesday.
SABCS® Program Director Kate Lathrop, MD, shares a few highlights from Thursday’s schedule to help you plan your day, including Poster Spotlight Sessions and notable General Session abstracts.
Don’t miss Thursday’s General Session abstract presentations and Poster Spotlight Session presentations, featuring research that has the potential to shape the future of breast cancer care.
Frederick Howard, MD, discusses a Thursday afternoon presentation on whether inflammatory breast cancer is a genomically different type of breast cancer.
Carsten F.J. Bakhuis discusses a Thursday evening poster presentation on worse prognosis for breast cancer in the second and third trimesters of pregnancy and shortly postpartum.
Neelima Vidula, MD, discusses a Thursday evening poster presentation on immune related adverse events in patients over 65 years of age vs. those younger than 65 years with breast cancer who were treated with immunotherapy.
Erika Hamilton, MD, discusses a Thursday evening poster presentation on the activity of ARV-471 in combination with a CDK4/6 inhibitor in patients with HR+ metastatic breast cancer.